scholarly journals Gastric bubble

2018 ◽  
Author(s):  
Daniel Bell ◽  
Dinesh Palipana
Keyword(s):  
Gastric Bubble

Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion

1992 ◽  
Vol 262 (2) ◽  
pp. R241-R244
Author(s):  
M. G. Boosalis ◽  
N. Gemayel ◽  
A. Lee ◽  
G. A. Bray ◽  
L. Laine ◽  
...  
Keyword(s):  
Gastric Volume ◽  
Time Dependent ◽  
Dependent Manner ◽  
Hypothalamic Obesity ◽  
Double Blind ◽  
Afferent Fibers ◽  
Hypothalamic Injury ◽  
Obese Subjects ◽  
Vagal Afferent ◽  
Gastric Bubble

Cholecystokinin (CCK) is a gut peptide whose proposed effect on satiety is thought to be related to gastric volume and to be signaled through vagal afferent fibers to the medial hypothalamus. To test these hypotheses we infused CCK C-terminal octapeptide (CCK-8) or saline in a random double-blind fashion in three groups of subjects: 17 obese subjects, 6 of whom subsequently received a gastric bubble, and 5 obese subjects whose obesity was due to hypothalamic injury. The number of sandwich canapes eaten after saline or CCK-8 infusion was recorded during three consecutive 10-min eating periods. Each subject served as his/her own control. The prior infusion of CCK-8 significantly decreased the consumption of sandwich canapes in the first eating period in both the control obese subjects and the subjects with obesity due to hypothalamic injury. Insertion of a gastric bubble did not enhance the satiety effect of CCK-8. These studies support the hypothesis that CCK produces satiety in a time-dependent manner that is not enhanced after the insertion of a gastric bubble but is operative in obese subjects with hypothalamic injury.

scholarly journals Small bowel obstruction due to Garren gastric bubble: radiographic diagnosis

1988 ◽  
Vol 150 (3) ◽  
pp. 581-582 ◽  
Author(s):  
RK Zeman ◽  
SB Benjamin ◽  
MB Cunningham ◽  
RJ Nauta ◽  
DF Fleischer ◽  
...  
Keyword(s):  
Small Bowel ◽  
Small Bowel Obstruction ◽  
Bowel Obstruction ◽  
Radiographic Diagnosis ◽  
Gastric Bubble

A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity

1989 ◽  
Vol 35 (5) ◽  
pp. 381-385 ◽  
Author(s):  
Reed B. Hogan ◽  
James H. Johnston ◽  
Billy W. Long ◽  
James Q. Sones ◽  
L. Ardell Hinton ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Double Blind ◽  
Gastric Bubble

A new method for gastric bubble removal

1987 ◽  
Vol 33 (3) ◽  
pp. 243-244 ◽  
Author(s):  
Mario Blinder ◽  
Robert I. Goldberg ◽  
Jamie S. Barkin ◽  
Richard S. Phillips
Keyword(s):  
New Method ◽  
Bubble Removal ◽  
Gastric Bubble

The gastric bubble

1987 ◽  
Vol 33 (5) ◽  
pp. 395-396
Author(s):  
Steven Brozinsky
Keyword(s):  
Gastric Bubble

Radiographic evaluation of the Garren gastric bubble

1985 ◽  
Vol 145 (1) ◽  
pp. 49-50 ◽  
Author(s):  
SL Edell ◽  
JS Wills ◽  
LR Garren ◽  
ML Garren
Keyword(s):  
Radiographic Evaluation ◽  
Gastric Bubble

Double-Blind Controlled Trial of the Garren-Edwards Gastric Bubble: An Adjunctive Treatment for Exogenous Obesity

1988 ◽  
Vol 95 (3) ◽  
pp. 581-588 ◽  
Author(s):  
Stanley B Benjamin ◽  
Kathleen A. Maher ◽  
Edward L. Cattau Jr. ◽  
Martin J. Collen ◽  
David E. Fleischer ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Adjunctive Treatment ◽  
Double Blind ◽  
Gastric Bubble

Complications of the Intragastric Balloon

2018 ◽  
Author(s):  
Ashok Menon ◽  
Haris A. Khwaja ◽  
Ariel Ortiz Lagardere ◽  
Manoel Galvao Neto ◽  
Jaime Ponce
Keyword(s):  
High Rate ◽  
Quality Data ◽  
Complication Rates ◽  
High Quality Data ◽  
Visceral Injury ◽  
Poor Weight Loss ◽  
Bariatric Patients ◽  
Treatment Of Obesity ◽  
Gastric Bubble

Intragastric balloons (IGB) have been used in the treatment of obesity for over 30 years. The first notable IGB device (the Garren Edwards Gastric Bubble) was withdrawn from the market due to patients’ poor weight loss and a high rate of complications. Several subsequent devices have been designed to address these shortcomings, but high-quality data are needed to compare complication rates among devices. Mortality across all IGB variants is extremely low compared to other bariatric procedures. Complications are mainly associated with visceral injury related to device insertion and retrieval, and with the presence or migration of an in-situ device, such as gastric ulceration and perforation, intolerance, gastrointestinal obstruction, and, rarely, acute pancreatitis. The incidence of postoperative venous thromboembolism (VTE) has not been extensively investigated, and it is not clear whether VTE is device-related or is due to increased VTE risk in bariatric patients.

Sign in / Sign up

Export Citation Format

Share Document